2, 2025 — A new, non-invasive nasal swab test for kids that diagnoses specific asthma subtype, or endotype, could help clinicians prescribe medications more precisely and pave the way for ...

Effective April 15, 2025, some patients will need to self-administer asthma medications at home rather than receiving them at a clinic. The affected medications include Fasenra, Tezspire ...

Peter Shadday becomes CEO as company is moving into a commercial-stage company, increasingly focused on U.S. market opportunitiesDr. Sabine ...

If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025 </stron ...

We came across a bullish thesis on Journey Medical Corporation (DERM) on Substack by The 10x Radar. In this article, we will ...

Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoid. If approved, Dupixent would be the first and only targeted medicine to treat BP in ...

When her son was diagnosed with severe heart problems, she blamed herself. Could she get over it? With her mother in labor, then-17-year-old Jamie Dawson sneaked past nurses and headed for the ...

Chime Biologics is committed to enabling Mabgeek in its strategic entry into the U.S. market and will continue to provide comprehensive CMC and regulatory support for the start of the Phase III ...

The US Food and Drug Administration (FDA) has accepted for priority review the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults with bullous pemphigoid (BP).

Seven Point lost their bid to open a cannabis consumption lounge at Tuesday’s City Council meeting. Aldermen voted 7-5 in favor of changing an ordinance that currently bans dispensaries from hosting ...